A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
Running, not enrolling · Phase 1/Phase 2
Conditions studied: Non-small Cell Lung Cancer, Lung Cancer
In brief
This study will compare Valemetostat Tosylate Plus Pembrolizumab vs Pembrolizumab Alone in First-line NSCLC Without Actionable Genomic Alterations
Key facts
- Study ID
- NCT06644768
- Run by
- Daiichi Sankyo
- People needed
- 137
- Starts
- 2024-10-30
- Expected to finish
- 2030-04-30
- Last updated by the study team
- 2026-07-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego (Ucsd)-Moores Cancer Center — La Jolla, California, United States
- California Research Institute — Los Angeles, California, United States
- Valkyrie Clinical Trials — Los Angeles, California, United States
- Mayo Clinic Hospital — Jacksonville, Florida, United States
- BRCR Global — Plantation, Florida, United States
- University of Kentucky Medical Center — Lexington, Kentucky, United States
- Pikeville Medical Center — Pikeville, Kentucky, United States
- Mayo Clinic - Rochester — Rochester, Minnesota, United States
- Columbia University Irving Medical Center — New York, New York, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center — Philadelphia, Pennsylvania, United States
- Virginia Cancer Specialist — Fairfax, Virginia, United States
- Hospital Italiano de Buenos Aires — Buenos Aires, Argentina
- Instituto Alexander Fleming — Buenos Aires, Argentina
- Sanatorio Allende — Córdoba, Argentina
- Fundacion Ars Medica — N Salvador de Jujuy, Argentina
- Instituto Medico de La Fundacion Estudios Clinicos — Rosario, Argentina
- Clinica Viedma S.A. — Viedma, Argentina
- Centro de Pesquisas Clinica Reichow — Blumenau, Brazil
- Clínica de Neoplasias Litoral Ltda. — ItajaĂ-, Brazil
- CINPAM Centro Integrado De Pesquisa Da Amazonia — Manaus, Brazil
- Liga Norte-Rio-Grandense Contra o Câncer — Natal, Brazil
- Hospital Nossa Senhora da Conceicao — Porto Alegre, Brazil
- Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto — Sao Jose Rio Preto, Brazil
- Jilin Cancer Hospital — Changchun, China
- Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine — Hangzhou, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.